Powered by the Evidence-based Practice Centers
Evidence Reports All of EHC
Evidence Reports All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers

White Paper Sep 30, 2006

Page Contents

The Eisenberg Center convenes scientific meetings for the discussion of state-of-the-art concepts in communication and medical decisionmaking. Experts in health communication, health literacy, shared decisionmaking, and related fields come together to produce high quality, scholarly white papers (and stakeholder commentaries) that offer insight into how state-of-the-art advances in medical science can be transformed into state-of-the-art clinical decisionmaking and improved health communication.

Publications

The papers from this conference were published in Medical Decision Making.

Evans WD, McCormack L. Applying social marketing in health care: communicating evidence to change consumer behavior. Med Decis Making 2008 Sep-Oct;28(5):781-92. PMID: 18556638

Lipkus IM. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making 2007 Sep-Oct;27(5):696-713. PMID: 17873259.

Politi MC, Han PKJ, Col NF. Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making 2007;27:681-95.PMID: 17873256

Presentation Summaries

For help viewing these proceedings, go to Viewers, Players, and Plug-ins.

Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (PPT, 153 kb)

What Do We Know About How Evidence of Harm and Benefit is Communicated in Other Countries?What Do We Know About How Evidence of Harm and Benefit is Communicated in Other Countries? (PPT, 2.7 MB)

Marketing Evidence to Healthcare Consumers Applying Social Marketing to Evidence About the Harms and Benefits of PharmaceuticalsMarketing "Evidence" to Healthcare Consumers: Applying Social Marketing to Evidence About the Harms and Benefits of Pharmaceuticals (PPT, 9.6 MB)

Communicating Harm and Benefits to Vulnerable PopulationsCommunicating Harm and Benefits to Vulnerable Populations (PPT, 57 kb)

Communicating the Harms and Benefits of Medical Treatments: A Look From Both Sides of the AisleCommunicating the Harms and Benefits of Medical Treatments: A Look From Both Sides of the Aisle (PPT, 1.0 MB)

Project Timeline

Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers (Eisenberg Center Conference Series 2006)

Sep 30, 2006
Topic Initiated
Sep 30, 2006
White Paper
Page last reviewed November 2017
Page originally created November 2017

Internet Citation: White Paper: Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers. Content last reviewed November 2017. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/products/eccs-2006/white-paper

Select to copy citation